Cure Today8 小时
Breaking Down the FDA Labeling Update of Xeloda and 5-FU in Cancer Care
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
Cure Today12 小时
THIO and Libtayo Extends OS in NSCLC Following Progression on SOC Therapy
THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...
Cure Today10 小时
The Effects of Scanxiety on ‘Normal’ Life
As a cancer survivor, I face added stress with an upcoming black belt test and "scanxiety" before my annual CT scan and ...
Cure Today6 小时
The Importance of Utilizing Support Networks Following a Cancer Diagnosis
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Cure Today11 小时
An Expert Breaks Down What DPD Is and Labeling Updates From The FDA
Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency.